drugset / Trial / NCT00198432

Chemoradiotherapy of NSCLC Stage IIIB

NCT00198432 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the best timing of the concomitant chemoradiotherapy among patients with NSCLC stage III not resectable treated by concomitant chemo-radiotherapy, either preceded by a induction chemotherapy, or followed by a consolidation chemotherapy.

Timeline

Start
2002-03
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 80 mg/m2 —
Subject Paclitaxel Small molecule 200 mg/m2 —
Subject Vinorelbine Small molecule 15 mg/m2 —